Mesenchymal properties of SJL mice-stem cells and their efficacy as autologous therapy in a relapsing-remitting multiple sclerosis model

Stem Cell Research and Therapy

Volumn 5, Issue 6, 2014, Pages

  Marin Bañasco, Carmen ^a   García, Margarita Suardíaz ^a   Guerrero, Issac Hurtado ^a   Sánchez, Rafael Maldonado ^a   Estivill Torrús, Guillermo ^a   Fernández, Laura Leyva ^a   Fernández, Oscar Fernández ^a  

^a Instituto de Biomedicina de Málaga IBIMA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; C57BL 6 MOUSE; CELL DIFFERENTIATION; CELL GROWTH; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL MEDICINE; FEMALE; HEMATOPOIETIC CELL; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; MOUSE MODEL; MULTIPLE SCLEROSIS; MULTIPOTENT STEM CELL; NONHUMAN; OSTEOCYTE; PRIORITY JOURNAL; STEM CELL CULTURE; STROMA CELL; SWISS JAMES LAMBERT MOUSE; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MESENCHYMAL STROMA CELL;

MUS;

ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL;

EID: 84927725007     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt524     Document Type: Article

References (47)

1. Mizuno H: Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review. J Nippon Med Sch Rev 2009, 76:56-66.
2. Mizuno H, Tobita M, Uysal AC: Concise review: Adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells 2012, 30:804-810.
3. Izadpanah R, Trygg C, Patel B, Kriedt C, Dufour J, Gimble JM, Bunnell BA: Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 2006, 99:1285-1297.
4. Constantin G, Marconi S, Rossi B, Angiari S, Calderan L, Anghiler E, Gini B, Bach SD, Martinello M, Bifari F, Galiè M, Turano E, Budui S, Sbarbati A, Krampera M, Bonetti B: Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 2009, 27:2624-2635.
5. Ben-Ami E, Berrih-Aknin S, Miller A: Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases. Autoimmun Rev 2011, 10: 410-415.
6. Tyndall A, Walker UA, Cope A, Dazzi F, De Bari C, Fibbe W, Guiducci S, Jones S, Jorgensen C, Le Blanc K, Luyten F, McGonagle D, Martin I, Bocelli-Tyndall C, Pennesi G, Pistoia V, Pitzalis C, Uccelli A, Wulffraat N, Feldmann M: Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther 2007, 9:301.
7. Uccelli A, Moretta L, Pistoia V: Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008, 8:726-736.
8. Freedman MS, Bar-Or A, Atkins HL, Karussis D, Frassoni F, Lazarus H, Scolding N, Slavin S, Le Blanc K, Uccelli A, MSCT Study Group: The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group. Mult Scler 2010, 16:503-510.
9. Bassi G, Pacelli L, Carusone R, Zanoncello J, Krampera M: Adipose-derived stromal cells (ASCs). Transfus Apher Sci 2012, 47:193-198.
10. Dominici M, Le BK, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8: 315-317.
11. Orbay H, Tobita M, Mizuno H: Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications. Stem Cells Int 2012, 2012:9. doi:10.1155/2012/461718.
12. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ: Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004, 103:1662-1668.
13. Fehrer C, Laschober G, Lepperdinger G: Aging of murine mesenchymal stem cells. Ann N Y Acad Sci 2006, 1067:235-242.
14. Ho AD, Wagner W, Franke W: Heterogeneity of mesenchymal stromal cell preparations [review]. Cytotherapy 2008, 10:320-330.
15. Sung HM, Yang JB, Park GS, Choi GS, Joh JW, Kwon CH, Chun JM, Lee SK, Kim SJ: Isolation and characterization of mouse mesenchymal stem cells. Transplant Proc 2008, 40:2649-2654.
16. Bochev I, Elmadjian G, Kyurkchiev D, Tzvetanov L, Altankova I, Tivchev P, Kyurkchiev S: Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biol Int 2008, 32:384-393.
17. Luo F, Hou TY, Zhang ZH, Xie Z, Wu XH, Xu JZ: Effects of initial cell density and hydrodynamic culture on osteogenic activity of tissue-engineered bone grafts. PLoS One 2013, 8:e53697.
18. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrichet R, Benes V, Blake J, Pfister S, Eckstein V, Ho AD: Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 2008, 3:e2213.
19. Meirelles LD, Nardi NB: Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol 2003, 123:702-711.
20. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K: Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006, 24:1294-1301.
21. Bieback K, Kern S, Kocaömer A, Ferlik K, Bugert P: Comparing mesenchymal stromal cells from different human tissues: bone marrow, adipose tissue and umbilical cord blood. Biomed Mater Eng 2008, 18:S71-S76.
22. Zhu Y, Liu T, Song K, Fan X, Ma X, Cui Z: Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem Funct 2008, 26:664-675.
23. Uccelli A, Laroni A, Freedman MS: Mesenchymal stem cells as treatment for MS - progress to date. Mult Scler J 2013, 19:515-519.
24. Barzilay R, Sadan O, Melamed E, Offen D: Comparative characterization of bone marrow-derived mesenchymal stromal cellsfrom four different rat strains. Cytotherapy 2009, 11:435-442.
25. Papenfuss TL, Rogers CJ, Gienapp I, Yurrita M, McClain M, Damico N, Valo J, Song F, Whitacre CC: Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J Neuroimmunol 2004, 150:59-69.
26. Krishnamoorthy G, Wekerle H: EAE: an immunologist's magic eye. Eur J Immunol 2009, 39:2031-2035.
27. Misharin AV, Haines GK 3rd, Rose S, Gierut AK, Hotchkiss RS, Perlman H: Development of a new humanized mouse model to study acute inflammatory arthritis. J Transl Med 2012, 10:190.
28. Chang B, Hawes NL, Hurd RE, Davisson MT, Nusinowitz S, Heckenlively JR: Retinal degeneration mutants in the mouse. Vision Res 2002, 42:517-525. Review.
29. Charles River. Products and Services. Basic Research. Find a model. [http://www.criver.com/find-a-model?animal-type=Mice]
30. Steinman L, Zamvil SS: Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol 2005, 26:565-571.
31. Gold R, Hartung HP, Toyka KV: Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today 2000, 6:88-91.
32. Steinman L, Zamvil SS: How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol 2006, 60:12-21.
33. Friese MA, Montalban X, Willcox N, Bell JI, Martin R, Fugger L: The value of animal models for drug development in multiple sclerosis. Brain 2006, 129:1940-1952.
34. Denic A, Johnson AJ, Bieber AJ, Warrington AE, Rodriguez M, Pirko I: The relevance of animal models in multiple sclerosis research. Pathophysiology 2011, 18:21-29.
35. Moreno B, Espejo C, Mestre L, Suardiaz M, Clemente D, de Castro F, Fernández-Fernández Ó, Montalban X, Villoslada P, Guaza C, Spanish Network for MS: Guidelines on the appropriate use of animal models for developing therapies in multiple sclerosis. Rev Neurol 2012, 54:114-124.
36. Miller S, Karpus W: Experimental autoimmune encephalomyelitis in the mouse. Curr Protoc Immunol 2007, Chapter 15:Unit 15.1.
37. Emerson MR, Gallagher RJ, Marquis JG, LeVine SM: Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design. Comp Med 2009, 59:112-128.
38. Mangalam AK, Poisson LM, Nemutlu E, Datta I, Denic A, Dzeja P, Rodriguez M, Rattan R, Giri S: Profile of circulatory metabolites in a relapsing-remitting animal model of multiple sclerosis using global metabolomics. J Clin Cell Immunol 2013, 4:4.
39. Soellner IA, Rabea J, Mauri V, Kaufmann J, Addicks J, Kuerten S: Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis. Clin Immunol 2013, 149:519-529.
40. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F, Mancardi G, Uccelli A: Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005, 106:1755-1761.
41. Schwartz M: A biomathematical approach to clinical tumos growth. Cancer 1961, 14:1272-1274.
42. Aoki T, Nakata H, Watanabe H, Nakamura K, Kasai T, Hashimoto H, Yasumoto K, Kido M: Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. Am J Roentgenol 2000, 174:763-768.
43. Yousefi F, Ebtekar M, Soleimani M, Soudi S, Hashemi S: Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissuemesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE). Int Immunopharmacol 2013, 17:608-616.
44. Estivill-Torrús G, Llebrez-Zayas P, Matas-Rico E, Santín L, Pedraza C, De Diego I, Del Arco I, Fernández-Llebrez P, Chun J, Rodríguez de Fonseca F: Absence of LPA1 signaling results in defective cortical development. Cereb Cortex 2008, 18:938-950.
45. Colter DC, Sekiya I, Prockop DJ: Identification of a subpopulation of rapidly selfrenewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A 2001, 98:7841-7845.
46. Zannettino AC, Paton S, Arthur A, Khor F, Itescu S, Gimble JM, Gronthos S: Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol 2008, 214:413-421.
47. Gerdoni E, Gallo B, Casazza S, Musio S, Bonanni I, Pedemonte E, Mantegazza R, Frassoni F, Mancardi G, Pedotti R, Uccelli A: Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 2007, 61: 219-227.